These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 9709948

  • 1. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis.
    Plotkin H, Gundberg C, Mitnick M, Stewart AF.
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2786-91. PubMed ID: 9709948
    [Abstract] [Full Text] [Related]

  • 2. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocaña A, Stewart AF.
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [Abstract] [Full Text] [Related]

  • 3. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF, Cain RL, Burr DB, Jacob D, Turner CH, Hock JM.
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid hormone-related protein-(1-36) is biologically active when administered subcutaneously to humans.
    Henry JG, Mitnick M, Dann PR, Stewart AF.
    J Clin Endocrinol Metab; 1997 Mar; 82(3):900-6. PubMed ID: 9062504
    [Abstract] [Full Text] [Related]

  • 5. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans.
    Everhart-Caye M, Inzucchi SE, Guinness-Henry J, Mitnick MA, Stewart AF.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):199-208. PubMed ID: 8550752
    [Abstract] [Full Text] [Related]

  • 6. Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis.
    Horwitz MJ, Tedesco MB, Gundberg C, Garcia-Ocana A, Stewart AF.
    J Clin Endocrinol Metab; 2003 Feb; 88(2):569-75. PubMed ID: 12574182
    [Abstract] [Full Text] [Related]

  • 7. Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.
    Tørring O, Turner RT, Carter WB, Firek AF, Jacobs CA, Heath H.
    Endocrinology; 1992 Jul; 131(1):5-13. PubMed ID: 1319327
    [Abstract] [Full Text] [Related]

  • 8. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover.
    Horwitz MJ, Tedesco MB, Sereika SM, Prebehala L, Gundberg CM, Hollis BW, Bisello A, Garcia-Ocaña A, Carneiro RM, Stewart AF.
    J Bone Miner Res; 2011 Sep; 26(9):2287-97. PubMed ID: 21544866
    [Abstract] [Full Text] [Related]

  • 9. Synthetic parathyroid hormone-like protein (1-74) is anabolic for bone in vivo.
    Weir EC, Terwilliger G, Sartori L, Insogna KL.
    Calcif Tissue Int; 1992 Jul; 51(1):30-4. PubMed ID: 1393774
    [Abstract] [Full Text] [Related]

  • 10. [Development of hPTHrP (1-36) as an anabolic therapeutic agent for osteoporosis].
    Takeuchi Y.
    Clin Calcium; 2011 Jan; 21(1):28-32. PubMed ID: 21187591
    [Abstract] [Full Text] [Related]

  • 11. A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study.
    Horwitz MJ, Augustine M, Khan L, Martin E, Oakley CC, Carneiro RM, Tedesco MB, Laslavic A, Sereika SM, Bisello A, Garcia-Ocaña A, Gundberg CM, Cauley JA, Stewart AF.
    J Bone Miner Res; 2013 Nov; 28(11):2266-76. PubMed ID: 23661240
    [Abstract] [Full Text] [Related]

  • 12. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 13. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
    Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Ocaña A, Bisello A, Hollis BW, Rosen CJ, Wysolmerski JJ, Dann P, Gundberg C, Stewart AF.
    J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
    [Abstract] [Full Text] [Related]

  • 14. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P, Alcaraz MJ.
    Biochem Pharmacol; 2013 May 15; 85(10):1417-23. PubMed ID: 23500550
    [Abstract] [Full Text] [Related]

  • 15. Role of dual signal transduction systems in the stimulation of bone resorption by parathyroid hormone-related peptide. The direct involvement of cAMP-dependent protein kinase.
    Kaji H, Sugimoto T, Fukase M, Chihara K.
    Horm Metab Res; 1993 Aug 15; 25(8):421-4. PubMed ID: 8225186
    [Abstract] [Full Text] [Related]

  • 16. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM.
    J Clin Invest; 1993 Mar 15; 91(3):1138-48. PubMed ID: 8450043
    [Abstract] [Full Text] [Related]

  • 17. PTHrP(1-36) as a skeletal anabolic agent for the treatment of osteoporosis.
    Stewart AF.
    Bone; 1996 Oct 15; 19(4):303-6. PubMed ID: 8894135
    [Abstract] [Full Text] [Related]

  • 18. Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: histomorphometric and biochemical investigations.
    Rosol TJ, Capen CC, Horst RL.
    J Bone Miner Res; 1988 Dec 15; 3(6):699-706. PubMed ID: 2855193
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats.
    Hock JM, Fonseca J, Gunness-Hey M, Kemp BE, Martin TJ.
    Endocrinology; 1989 Oct 15; 125(4):2022-7. PubMed ID: 2791976
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
    Cupp ME, Nayak SK, Adem AS, Thomsen WJ.
    J Pharmacol Exp Ther; 2013 Jun 15; 345(3):404-18. PubMed ID: 23516330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.